221 related articles for article (PubMed ID: 29909053)
1. Hymenoptera venom immunotherapy: Past, present, and future.
Oppenheimer J; Golden DBK
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
[No Abstract] [Full Text] [Related]
2. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.
Engler RJ; Davis WS
J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461
[No Abstract] [Full Text] [Related]
3. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
Ruëff F; Przybilla B
J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
[No Abstract] [Full Text] [Related]
4. [Highly purified toxin extracts for desensitization. Insect-sting allergy: a causal treatment is possible].
MMW Munch Med Wochenschr; 1979 Aug; 121(34):1057. PubMed ID: 114755
[No Abstract] [Full Text] [Related]
5. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
Ring J; Lonsdorf G; Schury W; Burg G
MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
[No Abstract] [Full Text] [Related]
6. [Desensitization of allergy to hymenoptera venoms].
Przybilla B; Ruëff F
Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
[TBL] [Abstract][Full Text] [Related]
7. [When can desensitization with bee and wasp venom be stopped?].
Oei HD; Stroes ES; Beukema WP; van der Zwan JC
Ned Tijdschr Geneeskd; 1991 Apr; 135(16):719-20. PubMed ID: 2038399
[No Abstract] [Full Text] [Related]
8. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
9. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab].
Wieczorek D; Kapp A; Wedi B
Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627
[TBL] [Abstract][Full Text] [Related]
10. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
Fricker M; Helbling A; Schwartz L; Müller U
J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
[TBL] [Abstract][Full Text] [Related]
11. A Case Study in Health Disparities: Barriers to Immunotherapy for Venom-Induced Anaphylaxis.
Satyavarapu I; Hein N; Carlson JC
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2568-2569. PubMed ID: 37301432
[No Abstract] [Full Text] [Related]
12. Stinging insect allergy and venom immunotherapy.
Gupta P; Greenberger PA
Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
[No Abstract] [Full Text] [Related]
13. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
14. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
Sabbah A; Bonneau JC; Drouet M; Le Sellin J
Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
[TBL] [Abstract][Full Text] [Related]
15. Venom extracts available to treat patients at risk from insect stings.
Gunby P
JAMA; 1979 May; 241(21):2243-6. PubMed ID: 439282
[No Abstract] [Full Text] [Related]
16. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
Müller UR; Golden DB; Demarco PJ; Lockey RF
Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
[No Abstract] [Full Text] [Related]
17. Discontinuation of venom immunotherapy.
Golden DB
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):703-4. PubMed ID: 9802387
[No Abstract] [Full Text] [Related]
18. Mary Hewitt Loveless, MD: The origin of venom immunotherapy.
Galli SJ
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):268-271. PubMed ID: 29964225
[No Abstract] [Full Text] [Related]
19. The sting challenge test in Hymenoptera venom allergy: pros and cons.
Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
